Robust patent strategy

Orexo’s business is underpinned by a robust patent portfolio that covers all commercial products and pipeline assets. The AmorphOX^® platform is a core technology, and the company continuously strengthens its intellectual property protection for this innovative, powder-based platform.

The company’s patent strategy is to establish appropriate protection in the key markets for each product. Product-specific patents represent important assets, and the strategy includes securing enforceable patents that are eligible for listing in the FDA “Orange Book” for all drug products intended for the US market.

Orexo has an in-house IP department that works in close collaboration with innovators, development teams, and external counsel to ensure that all aspects of the innovation process are protected, thereby laying the foundation for patents in the portfolio. Orexo’s global experience in patent enforcement is an invaluable asset that helps shape its overall patent strategy.